Canada markets closed

CTT Pharmaceutical Holdings, Inc. (CTTH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0351-0.0049 (-12.25%)
At close: 03:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.94M
Enterprise Value 1.94M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.83

Trading Information

Stock Price History

Beta (5Y Monthly) 0.25
52-Week Change 3263.64%
S&P500 52-Week Change 325.38%
52 Week High 30.1000
52 Week Low 30.0030
50-Day Moving Average 30.0344
200-Day Moving Average 30.0260

Share Statistics

Avg Vol (3 month) 318.84k
Avg Vol (10 day) 36.77k
Shares Outstanding 548.39M
Implied Shares Outstanding 660.02M
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Aug 28, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2014
Most Recent Quarter (mrq)Sept 30, 2015

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-153.57%
Return on Equity (ttm)-448.83%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.67M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.12k
Total Cash Per Share (mrq)0
Total Debt (mrq)87.62k
Total Debt/Equity (mrq)11.87%
Current Ratio (mrq)5.01
Book Value Per Share (mrq)0.04

Cash Flow Statement

Operating Cash Flow (ttm)-131.17k
Levered Free Cash Flow (ttm)-216.98k